Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Hunan provincial people’s hospital | China

AUTHOR PROFILE

Scopus

🌟Wu Yaqin 

πŸ₯CURRENT ROLES AND AFFILIATIONSΒ 

  • Current Position: Organizational Committee Member, Graduate Student Party Branch
  • Graduate Institution: Hunan Provincial People’s Hospital (Hunan Normal University First Affiliated Hospital), Breast and Thyroid Surgery, Master’s Supervisor: Professor Zhang Chaojie
  • Undergraduate Institution: Hunan Normal University Medical School, Clinical Medicine (2014.9–2019.6)

πŸ“šEARLY ACADEMIC PURSUITSΒ 

Wu Yaqin began her academic journey at Hunan Normal University Medical School, excelling in Clinical Medicine. Her undergraduate years were marked by stellar academic performance, with scholarships awarded every year, including National Scholarship and National Inspirational Scholarship.

πŸ”¬PROFESSIONAL ENDEAVORSΒ 

Currently pursuing a Master’s degree in Surgery (Breast and Thyroid Surgery) at Hunan Provincial People’s Hospital, Wu has honed her clinical and research skills. She has gained recognition for:

  1. Outstanding clinical rotation performance.
  2. Active participation in surgeries, assisting in level 3 and 4 operations.
  3. Representing her hospital in Clinical Skills Competitions.

πŸ§ͺCONTRIBUTIONS AND RESEARCH FOCUSΒ 

Wu Yaqin has a strong foundation in research and innovation, focusing on:

  • Scientific Techniques: Proficiency in WB, PCR, single-cell sequencing, metabolomics, and other experimental skills.
  • Data Analysis: Skilled in SPSS, bioinformatics, and advanced statistical analysis.
  • Publications:
    • 2 SCI papers as the first and corresponding author (Cumulative Impact Factor: 5.143).
    • 2 core journal publications in China.
  • Research Projects:
    • Contributed to two provincial-level projects and two horizontal projects as the lead researcher (under mentor guidance).

🌟IMPACT AND INFLUENCE 

Wu’s contributions extend beyond academia:

  • Regularly earns recognition as an Outstanding Party Member, Student, and Graduate.
  • Actively involved in expert consensus compilation, adding to professional guidelines.
  • Participates in large-scale event organization with exceptional planning and execution skills.

PERSONAL SKILLS AND INTERESTS πŸŽ™οΈ

  • Language Proficiency:
    • Passed CET-4 and CET-6.
    • Achieved Grade 2-A in the National Mandarin Test.
  • Technical Skills:
    • Proficient in basic and advanced experimental techniques.
    • Skilled in computer applications (provincial-level certification).
  • Special Interests: Broadcasting, hosting, debate, and recitation.

RECOGNITION AND HONORS πŸ…

During Master’s Program:

  • Authored high-impact research papers.
  • Contributed to prestigious projects and received multiple awards for academic excellence.

During Undergraduate Program:

  • Awarded numerous scholarships and honors.
  • Served in various leadership roles:
    • Vice Minister, Learning Department of the Student Union.
    • Captain, Debate Team.
    • Psychological Committee Member, Class Representative.

LEGACY AND FUTURE CONTRIBUTIONS 🌐

Wu Yaqin’s dedication to clinical excellence, innovative research, and effective communication positions her as a rising star in medical sciences. She is committed to:

  1. Advancing clinical practice and surgical expertise.
  2. Expanding her impact through cutting-edge research and mentorship roles.
  3. Building a legacy of leadership and service within the medical community.

 

πŸ“ŠπŸ”¬NOTABLE PUBLICATION:
  • 1. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    • Authors: Huang, S.-L., Huang, Z.-C., Zhang, C.-J., Wu, Y.-Q., Fan, P.-Z.
    • Journal: Breast Cancer
    • Year: 2022

    2. The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis

    • Authors: Kong, C., Zhang, C., Wu, Y., He, J., Fan, P.
    • Journal: Gland Surgery
    • Year: 2020

    3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

    • Authors: Wang, H., Fang, Q., You, S., Wu, Y., Zhang, C.
    • Journal: Genes and Genomics
    • Year: 2023

    4. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

    • Authors: Xiao, X., Wu, Y., Zou, L., Chen, Y., Zhang, C.
    • Journal: Gland Surgery
    • Year: 2022

    5. A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis

    • Authors: Zhang, C., Wu, Y., Wang, H., Li, Q., Fan, P.
    • Journal: Gland Surgery
    • Year: 2021

Assoc. Prof. Dr. Shi-liang Huang | Tumor | Best Researcher Award

Assoc. Prof. Dr. Shi-liang Huang | Tumor | Best Researcher Award

Sun Yat-sen University | China

AUTHOR PROFILE

Scopus

ORCID ID

πŸ§‘β€πŸ”¬ DR. SHI-LIANG HUANG

Associate Professor in Medicinal Chemistry
Sun Yat-sen University, People’s Republic of China

🎯 OBJECTIVE

Dedicated Associate Professor specializing in Medicinal Chemistry, with a passion for driving innovation in drug discovery and development, focusing on the tumor microenvironment and the heat shock response.

πŸ“˜ EARLY ACADEMIC PURSUITS

Dr. Huang’s academic journey began with a solid foundation in Chemistry and Biochemistry, laying the groundwork for a distinguished career. After excelling in undergraduate studies, Dr. Huang pursued advanced degrees in Medicinal Chemistry, demonstrating exceptional aptitude for research and innovation.

Key achievements during this phase include:

  • Master’s Thesis: Groundbreaking work on natural product derivatives for therapeutic applications.
  • Doctoral Research: Advanced studies on the mechanisms of small molecules in altering biochemical pathways.

🏒 PROFESSIONAL ENDEAVORS

As an Associate Professor at Sun Yat-sen University, Dr. Huang has significantly contributed to the university’s reputation as a leading institution in medicinal research. His professional journey is marked by:

  • Leading Interdisciplinary Teams: Collaborating with experts in oncology, biochemistry, and computational modeling.
  • Research Innovation: Pioneering techniques in synthesizing inhibitors targeting heat shock proteins (HSPs) and heat shock factor 1 (HSF1).
  • Teaching Excellence: Mentoring students in natural medicinal chemistry and drug design methodologies.

πŸ§ͺ CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Huang’s work revolves around integrating bioorganic chemistry with tumor microenvironment studies to innovate cancer therapies. Key contributions include:

  • Medicinal Chemistry: Developing novel molecules with high specificity for cancer-related targets.
  • Natural Product Exploration: Isolating and modifying natural compounds to enhance their therapeutic potential.
  • Heat Shock Response Modulation: Designing inhibitors to disrupt HSF1 and HSP pathways, which are critical in cancer cell survival under stress.
  • Tumor Microenvironment Studies: Investigating how microenvironmental factors influence drug efficacy.

🌟 IMPACT AND INFLUENCE

Dr. Huang’s research has had a profound impact on the scientific community and beyond:

  • Published Works: Author of numerous peer-reviewed articles in high-impact journals.
  • Citations and Recognition: Garnered widespread academic citations, reflecting the influence and applicability of his research.
  • Collaboration and Leadership: Actively involved in global collaborations, enhancing the translational impact of his findings.

πŸ“Š ACADEMIC CITATIONS AND METRICS

Dr. Huang’s academic metrics underscore his scholarly contributions:

  • H-Index: Demonstrates significant citation impact in medicinal chemistry and oncology.
  • Published Articles: Over 50 research papers, including breakthroughs in bioorganic and natural medicinal chemistry.
  • Research Grants: Secured funding for multiple national and international projects.

πŸ† LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in drug discovery, Dr. Huang aspires to expand his research impact by:

  • Advancing precision medicine approaches tailored to the tumor microenvironment.
  • Developing next-generation inhibitors targeting stress-response proteins in cancer therapy.
  • Mentoring the next wave of researchers in innovative medicinal chemistry.

🌏 CONCLUSION

Dr. Shi-liang Huang embodies a blend of academic rigor, research innovation, and educational leadership. His contributions continue to shape the future of medicinal chemistry, with a legacy that inspires collaboration, discovery, and impactful solutions in cancer therapy.

πŸ“ŠπŸ”¬NOTABLE PUBLICATION:
  • A Novel HSF1 Activator Ameliorates Non-Alcoholic Steatohepatitis by Stimulating Mitochondrial Adaptive Oxidation
    • Authors: Rao, Y.; Li, C.; Hu, Y.-T.; Ye, J.-M.; Huang, Z.-S.
    • Journal: British Journal of Pharmacology
    • Year: 2022

 

  • Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective c-MYC Transcription Repressors Targeting the Promoter G-Quadruplex
    • Authors: Li, M.-L.; Yuan, J.-M.; Yuan, H.; Chen, S.-B.; Huang, Z.-S.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2022

 

  • Discovery of Quinacrine as a Potent Topo II and Hsp90 Dual-Target Inhibitor, Repurposing for Cancer Therapy
    • Authors: Pan, X.; Mao, T.-Y.; Mai, Y.-W.; Huang, Z.-S.; Huang, S.-L.
    • Journal: Molecules
    • Year: 2022

 

  • Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer
    • Authors: Jiang, X.-C.; Tu, F.-H.; Wei, L.-Y.; Chen, S.-B.; Huang, Z.-S.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2022

 

  • Design and Synthesis of Bouchardatine Derivatives as a Novel AMP-Activated Protein Kinase Activator for the Treatment of Colorectal Cancer
    • Authors: Xu, Y.-H.; Hu, Y.-T.; Xu, S.-M.; Chen, S.-B.; Huang, Z.-S.
    • Journal: Journal of Medicinal Chemistry
    • Year: 2023